Holy Cross
fills gap - no delete

Parent's Corner

EpiPens Recall

People who carry EpiPens should take a close look at the packaging. Certain lots of the potentially life-saving product are being recalled.

The U.S. Food and Drug Administration is alerting consumers to the voluntary recall of 13 lots of Meridian Medical Technologies EpiPen and EpiPen Jr Auto-Injector products used for emergency treatment of severe allergic reactions. The recall is due to the potential that the devices may contain a defective part that may result in the devices' failure to activate. 

While the number of reported failures is small, the FDA said EpiPen products that potentially contain a defective part are being recalled because of the potential for life-threatening risk if a severe allergic reaction goes untreated. 

The specified lots of the device are the only EpiPen lots impacted by the recall at this time. Anyone with EpiPens from lots not included do not need to replace their device prior to its expiration date. The recalled lots are listed below. 

  • EpiPen Jr Auto-Injector, 0.15 mg, NDC # 49502-501-02, Lot # 5GN767, April 2017
  • EpiPen Jr Auto-Injector, 0.15 mg, NDC # 49502-501-02, Lot # 5GN773, April 2017
  • EpiPen Auto-Injector, 0.3 mg, NDC # 49502-500-02, Lot # 5GM631, April 2017
  • EpiPen Auto-Injector, 0.3 mg, NDC # 49502-500-02, Lot # 5GM640, May 2017
  • EpiPen Jr Auto-Injector, 0.15 mg, NDC # 49502-501-02, Lot # 6GN215, September 2017
  • EpiPen Auto-Injector, 0.3 mg, NDC # 49502-500-02, Lot # 6GM082, September 2017
  • EpiPen Auto-Injector, 0.3 mg, NDC # 49502-500-02, Lot # 6GM072, September 2017
  • EpiPen Auto-Injector, 0.3 mg, NDC # 49502-500-02, Lot # 6GM081, September 2017
  • EpiPen Auto-Injector, 0.3 mg, NDC # 49502-500-02, Lot # 6GM088, October 2017
  • EpiPen Auto-Injector, 0.3 mg, NDC # 49502-500-02, Lot # 6GM199, October 2017
  • EpiPen Auto-Injector, 0.3 mg, NDC # 49502-500-02, Lot # 6GM091, October 2017
  • EpiPen Auto-Injector, 0.3 mg, NDC # 49502-500-02, Lot # 6GM198, October 2017
  • EpiPen Auto-Injector, 0.3 mg, NDC # 49502-500-02, Lot # 6GM087, October 2017

Anyone with the recalled EpiPen should keep and use them as needed until they get a replacement. Always seek emergency medical help after using their EpiPens, especially if the device did not activate. Consumers should contact Mylan at 800-796-9526 or customer.service@mylan.com with any questions.

Tamber Schorey